Sight Sciences Statistics
Share Statistics
Sight Sciences has 51.33M
shares outstanding. The number of shares has increased by 3.17%
in one year.
| Shares Outstanding | 51.33M |
| Shares Change (YoY) | 3.17% |
| Shares Change (QoQ) | 1.14% |
| Owned by Institutions (%) | 44.91% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 8,739 |
| FTD / Avg. Volume | 3.51% |
Short Selling Information
The latest short interest is 1.33M, so 2.57% of the outstanding
shares have been sold short.
| Short Interest | 1.33M |
| Short % of Shares Out | 2.57% |
| Short % of Float | 3.57% |
| Short Ratio (days to cover) | 7.67 |
Valuation Ratios
The PE ratio is -3.54 and the forward
PE ratio is -3.46.
Sight Sciences's PEG ratio is
0.37.
| PE Ratio | -3.54 |
| Forward PE | -3.46 |
| PS Ratio | 2.28 |
| Forward PS | 1.9 |
| PB Ratio | 2.09 |
| P/FCF Ratio | -8.03 |
| PEG Ratio | 0.37 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Sight Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04,
with a Debt / Equity ratio of 0.46.
| Current Ratio | 9.04 |
| Quick Ratio | 8.63 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | -0.88 |
| Debt / FCF | -1.78 |
| Interest Coverage | -10.84 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $369,750 |
| Profits Per Employee | $-238,458.33 |
| Employee Count | 216 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.83 |
Taxes
| Income Tax | 236K |
| Effective Tax Rate | -0.46% |
Stock Price Statistics
The stock price has increased by -41.14% in the
last 52 weeks. The beta is 2.4, so Sight Sciences's
price volatility has been higher than the market average.
| Beta | 2.4 |
| 52-Week Price Change | -41.14% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 4.17 |
| Relative Strength Index (RSI) | 64.73 |
| Average Volume (20 Days) | 248,816 |
Income Statement
In the last 12 months, Sight Sciences had revenue of 79.87M
and earned -51.51M
in profits. Earnings per share was -1.03.
| Revenue | 79.87M |
| Gross Profit | 68.28M |
| Operating Income | -50.53M |
| Net Income | -51.51M |
| EBITDA | -45.9M |
| EBIT | -46.61M |
| Earnings Per Share (EPS) | -1.03 |
Full Income StatementBalance Sheet
The company has 120.36M in cash and 40.36M in
debt, giving a net cash position of 80M.
| Cash & Cash Equivalents | 120.36M |
| Total Debt | 40.36M |
| Net Cash | 80M |
| Retained Earnings | -346.3M |
| Total Assets | 142.84M |
| Working Capital | 124.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -22.35M
and capital expenditures -385K, giving a free cash flow of -22.74M.
| Operating Cash Flow | -22.35M |
| Capital Expenditures | -385K |
| Free Cash Flow | -22.74M |
| FCF Per Share | -0.45 |
Full Cash Flow StatementMargins
Gross margin is 85.5%, with operating and profit margins of -63.27% and -64.49%.
| Gross Margin | 85.5% |
| Operating Margin | -63.27% |
| Pretax Margin | -64.2% |
| Profit Margin | -64.49% |
| EBITDA Margin | -57.47% |
| EBIT Margin | -63.27% |
| FCF Margin | -28.47% |
